Thursday, January 24, 2013

• 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet (Thu, Jan 24)

Wednesday, January 23, 2013

• Healthcare Recap: Earnings, Drug Trials, and Liquidationat Wall St. Cheat Sheet (Wed, Jan 23)
• Vanda says sleep drug met goal in clinical trialAP (Wed, Jan 23)
• Vanda Announces Positive Results in the Second Phase III Study of Tasimelteon for the Treatment of Non-24-Hour Disorder -Conference Call scheduled for 9:00 am ET todayCCBN (Wed, Jan 23)
• Vanda announces positive results in second Phase III study of Tasimelteonat theflyonthewall.com (Wed, Jan 23)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 23)

Wednesday, December 26, 2012

• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, Dec 26)

Tuesday, December 25, 2012

• Three Odd Quant Stories: Odd Stocks, Network Connections and Insider Buyingat Forbes (Tue, Dec 25)

Wednesday, December 19, 2012

• Stock Watch Wednesday, 19 Decemberat Seeking Alpha (Wed, Dec 19)
• Four Companies That Stuck Out on Tuesday; and that Might Trade Higherat Motley Fool (Wed, Dec 19)

Tuesday, December 18, 2012

• Pfizer Slashes Sales Jobs, Merck & GE Affiliate Collaborate: Healthcare Business Updateat Wall St. Cheat Sheet (Tue, Dec 18)
• Vanda Pharmaceuticals rises on sleep drug resultsAP (Tue, Dec 18)
• Vanda Pharmaceuticals sees breakthrough in testing of sleep drugat bizjournals.com (Tue, Dec 18)
• Arbitron spikes with Nielsen buyoutoptionMONSTER (Tue, Dec 18)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Dec 18)

Monday, December 17, 2012

• Weekly Stock Watch, Week Of 17 Decemberat Seeking Alpha (Mon, Dec 17)

Friday, December 14, 2012

• Sanofi & Isis Report Negative EU Opinion, Cytori’s Stock Offering: Healthcare Business Recapat Wall St. Cheat Sheet (Fri, Dec 14)
• Vanda Pharmaceuticals shares fall as Europe rejects schizophrenia drugat bizjournals.com (Fri, Dec 14)
• Vanda's Fanaptum refused marketing authorization by European Medicines Agencyat theflyonthewall.com (Fri, Dec 14)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Dec 14)

Thursday, November 8, 2012

• VANDA PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)

Wednesday, November 7, 2012

• Vanda Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Nov 7)
• Vanda Pharmaceuticals loss widensat bizjournals.com (Wed, Nov 7)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online (Wed, Nov 7)

Monday, October 15, 2012

• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Oct 15)

Add VNDA News to My Yahoo!